维普中文期刊产品整合服务
160篇 您的检索式:作者名="Fonseca VA"
    题名 作者 年代 出处 被引量
1Systematic review:glucose control and cardiovascular disease in type 2 diabetes显示文摘Kelly TN Bazzano LA Fonseca VA Annals of Internal Medicine0,,:2
2Renal sodium-glucose transport : role in diabetes mellitus and potentialclinical implications 显示文摘Bakris GL* Fonseca VA Sharma K 2009Kidney Int2009,75,12:1
3The effectiveness of inten- sive glycemic control for the prevention of vascuku' complications in diabetes mellitus显示文摘Vasudevan AR Burns A Fonseca VA 2006Treat Endocrino12006,5,5:1
4Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects显示文摘Fonseca VA Mudaliar S Srhmidt B 1998Metabolism1998,47,:1
5Emerging concepts in the pathophysiology of type 2diabetes mellitus显示文摘Surampudi PN John-Kalarickal J Fonseca VA 2009Mt Sinai J Med2009,76,3:1
6Plasma homocysteine concentrations are regulated by acute hyperlnsulinemia in nondiabetic but not type 2 diabetic subjects显示文摘Fonseca VA Mudaliar S Schmidt B 1998Metabolism1998,47,6:1
7Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in non diabetic but not type 2 diabetic显示文摘Fonseca VA Mudaliar S Schmidt B 0,,06:1
8The metabolic syndrome,hyperlipidemia,and insulin resistance显示文摘Fonseca VA 2005Clin Cornerstone2005,7,2:1
9Efficacy and safety of the oncedaily GLP-1 receptor agonist lixisenatide in monotherapy:a randomized,double-blind,placebo-controlled trial in patients with type 2 diabetes(Get Goal-Mono)显示文摘Fonseca VA Alvarado-Ruiz R Raccah D 2012Diabetes Care2012,35,6:1
10Plasma homocysteine concerntrations are regulated by acute hyperinsulinmia in nondiabetic but not type 2 diabetic subjects显示文摘Fonseca VA Mudaliar S Schmidt B 1998Metabolism1998,47,:1
11Effi- cacy and safety of the once-daily GLP-1 receptor agonist lixisen- atide in monotherapy: a randomized, double-blind, placebo-con- trolled trial in patients with type 2 diabetes (GetGoal-Mono) 显示文摘FONSECA VA ALVARADO-RUIZ R RACCAH D 2012Diabetes Care2012,35,6:1
12Emerging concepts in the pathophysiology of type 2 diabetes mellitus 显示文摘Surampudi PN John-Kalarickal J Fonseca VA 2009Mt Sinai J Med2009,76,3:1
13Effects of -bloekers on glucose and lipid metabo- lism显示文摘Fonseca VA 2010Curr Med Res Opin2010,26,3:1
14Inflammation,insulinresistance,and atherosclerosis显示文摘Theuma P Fonseca VA 2004Metab Syndr Relat Disord2004,2,2:1
15Role of insulin secretagogues and insulin sensitizing agents in the prevention of cardiovascular disease in patients who have diabetes显示文摘Jawa AA Fonseca VA 2005Cardiol Clin2005,23,:1
16The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase:studies in hepatocytes显示文摘 Fonseca VA Fink Lid 2001Atheroseleresis2001,158,2:1
17Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects 显示文摘Fonseca VA Fink LM Kern PA 2003Atherosclerosis2003,167,1:1
18Insulin sensitivity and plasma homocysteine concentrations in non 2 diabetic obese and normal weight subjects显示文摘Fonseca VA Fink LM Kem PA 2003Atherosclerosis2003,167,:1
19Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects显示文摘Fonseca VA Fink LM Kern PA 0,,01:1
20The effectiveness of intensive glycemic control for the prevention of vascular comp lications in diabetes mellitus:source treatments in en- docrinology显示文摘Vasudevan AR Burns A Fonseca VA 2006Treat Endocrinol2006,5,5:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费